Literature DB >> 22219187

Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2.

Pan Chen1, Zilin Song, Yonghe Qi, Xiaofeng Feng, Naiqing Xu, Yinyan Sun, Xing Wu, Xin Yao, Qunyin Mao, Xiuling Li, Wenjuan Dong, Xiaobo Wan, Niu Huang, Xinliang Shen, Zhenglun Liang, Wenhui Li.   

Abstract

Enterovirus 71 (EV71) is one of the major pathogens that cause hand, foot, and mouth disease outbreaks in young children in the Asia-Pacific region in recent years. Human scavenger receptor class B 2 (SCARB2) is the main cellular receptor for EV71 on target cells. The requirements of the EV71-SCARB2 interaction have not been fully characterized, and it has not been determined whether SCARB2 serves as an uncoating receptor for EV71. Here we compared the efficiency of the receptor from different species including human, horseshoe bat, mouse, and hamster and demonstrated that the residues between 144 and 151 are critical for SCARB2 binding to viral capsid protein VP1 of EV71 and seven residues from the human receptor could convert murine SCARB2, an otherwise inefficient receptor, to an efficient receptor for EV71 viral infection. We also identified that EV71 binds to SCARB2 via a canyon of VP1 around residue Gln-172. Soluble SCARB2 could convert the EV71 virions from 160 S to 135 S particles, indicating that SCARB2 is an uncoating receptor of the virus. The uncoating efficiency of SCARB2 significantly increased in an acidic environment (pH 5.6). These studies elucidated the viral capsid and receptor determinants of enterovirus 71 infection and revealed a possible target for antiviral interventions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22219187      PMCID: PMC3307280          DOI: 10.1074/jbc.M111.301622

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis.

Authors:  L C Lum; K T Wong; S K Lam; K B Chua; A Y Goh
Journal:  Lancet       Date:  1998-10-24       Impact factor: 79.321

2.  Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification.

Authors:  M S Oberste; K Maher; D R Kilpatrick; M A Pallansch
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

3.  Comparative protein modelling by satisfaction of spatial restraints.

Authors:  A Sali; T L Blundell
Journal:  J Mol Biol       Date:  1993-12-05       Impact factor: 5.469

4.  Entry of poliovirus into cells does not require a low-pH step.

Authors:  L Pérez; L Carrasco
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

5.  An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group.

Authors:  M Ho; E R Chen; K H Hsu; S J Twu; K T Chen; S F Tsai; J R Wang; S R Shih
Journal:  N Engl J Med       Date:  1999-09-23       Impact factor: 91.245

6.  The essential role of clathrin-mediated endocytosis in the infectious entry of human enterovirus 71.

Authors:  Khairunnisa' Mohamed Hussain; Kim Lian Janet Leong; Mary Mah-Lee Ng; Justin Jang Hann Chu
Journal:  J Biol Chem       Date:  2010-10-18       Impact factor: 5.157

7.  Structure of a human rhinovirus complexed with its receptor molecule.

Authors:  N H Olson; P R Kolatkar; M A Oliveira; R H Cheng; J M Greve; A McClelland; T S Baker; M G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

8.  The residues Leu(Ile)475-Ile(Leu, Val, Ala)476, contained in the extended carboxyl cytoplasmic tail, are critical for targeting of the resident lysosomal membrane protein LIMP II to lysosomes.

Authors:  I V Sandoval; J J Arredondo; J Alcalde; A Gonzalez Noriega; J Vandekerckhove; M A Jimenez; M Rico
Journal:  J Biol Chem       Date:  1994-03-04       Impact factor: 5.157

9.  Antiviral agent blocks breathing of the common cold virus.

Authors:  J K Lewis; B Bothner; T J Smith; G Siuzdak
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

10.  Fatal case of enterovirus 71 infection, France, 2007.

Authors:  Sophie Vallet; Marie Christine Legrand Quillien; Thomas Dailland; Gaëtan Podeur; Stéphanie Gouriou; Isabelle Schuffenecker; Christopher Payan; Pascale Marcorelles
Journal:  Emerg Infect Dis       Date:  2009-11       Impact factor: 6.883

View more
  62 in total

1.  Single Neutralizing Monoclonal Antibodies Targeting the VP1 GH Loop of Enterovirus 71 Inhibit both Virus Attachment and Internalization during Viral Entry.

Authors:  Zhiqiang Ku; Xiaohua Ye; Jinping Shi; Xiaoli Wang; Qingwei Liu; Zhong Huang
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

2.  Human enterovirus 71 uncoating captured at atomic resolution.

Authors:  Ke Lyu; Jie Ding; Jian-Feng Han; Yu Zhang; Xiao-Yan Wu; Ya-Ling He; Cheng-Feng Qin; Rong Chen
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

3.  Activity-Based Protein Profiling Identifies ATG4B as a Key Host Factor for Enterovirus 71 Proliferation.

Authors:  Yang Sun; Qizhen Zheng; Yaxin Wang; Zhengyuan Pang; Jingwei Liu; Zheng Yin; Zhiyong Lou
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

4.  VP1 Amino Acid Residue 145 of Enterovirus 71 Is a Key Residue for Its Receptor Attachment and Resistance to Neutralizing Antibody during Cynomolgus Monkey Infection.

Authors:  Ken Fujii; Yui Sudaka; Ayako Takashino; Kyousuke Kobayashi; Chikako Kataoka; Tadaki Suzuki; Naoko Iwata-Yoshikawa; Osamu Kotani; Yasushi Ami; Hiroyuki Shimizu; Noriyo Nagata; Katsumi Mizuta; Yoko Matsuzaki; Satoshi Koike
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

5.  Identification of Positively Charged Residues in Enterovirus 71 Capsid Protein VP1 Essential for Production of Infectious Particles.

Authors:  Shilin Yuan; Guiming Li; Ying Wang; Qianqian Gao; Yizhuo Wang; Rui Cui; Ralf Altmeyer; Gang Zou
Journal:  J Virol       Date:  2015-10-28       Impact factor: 5.103

6.  Neutralizing antibodies can initiate genome release from human enterovirus 71.

Authors:  Pavel Plevka; Pei-Yin Lim; Rushika Perera; Jane Cardosa; Ampa Suksatu; Richard J Kuhn; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

7.  A novel finding for enterovirus virulence from the capsid protein VP1 of EV71 circulating in mainland China.

Authors:  Yongjuan Liu; Chong Fu; Suying Wu; Xiong Chen; Yingying Shi; Bingfei Zhou; Lianglu Zhang; Fengfeng Zhang; Zhihao Wang; Yingying Zhang; Chengpeng Fan; Song Han; Jun Yin; Biwen Peng; Wanhong Liu; Xiaohua He
Journal:  Virus Genes       Date:  2014-01-19       Impact factor: 2.332

8.  Unraveling the Motions behind Enterovirus 71 Uncoating.

Authors:  Caroline J Ross; Ali Rana Atilgan; Özlem Tastan Bishop; Canan Atilgan
Journal:  Biophys J       Date:  2018-02-27       Impact factor: 4.033

9.  Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor.

Authors:  Chee Wah Tan; Chit Laa Poh; I-Ching Sam; Yoke Fun Chan
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

10.  A Single Mutation in the VP1 of Enterovirus 71 Is Responsible for Increased Virulence and Neurotropism in Adult Interferon-Deficient Mice.

Authors:  Elizabeth A Caine; Louise H Moncla; Monica D Ronderos; Thomas C Friedrich; Jorge E Osorio
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.